1992
DOI: 10.1016/0016-5085(92)91094-k
|View full text |Cite
|
Sign up to set email alerts
|

Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
375
0
9

Year Published

1999
1999
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 670 publications
(389 citation statements)
references
References 28 publications
5
375
0
9
Order By: Relevance
“…Although a decreased butyrate oxidation was observed in active ulcerative colitis (Den Hond et al, 1998), there was, however, no difference between controls and patients with quiescent colitis, speaking against a primary defect in colonic butyrate oxidation (Simpson et al, 2000). Some studies demonstrate a therapeutic effect of rectal butyrate and mixed CAs in distal colitis (Scheppach et al, 1992;Vernia et al, 2003). Although well-controlled clinical trials have not fully verified this finding (Scheppach, 1996;Steinhart et al, 1996), they suggest that butyrate may be effective in a subset of patients.…”
Section: Introductionmentioning
confidence: 99%
“…Although a decreased butyrate oxidation was observed in active ulcerative colitis (Den Hond et al, 1998), there was, however, no difference between controls and patients with quiescent colitis, speaking against a primary defect in colonic butyrate oxidation (Simpson et al, 2000). Some studies demonstrate a therapeutic effect of rectal butyrate and mixed CAs in distal colitis (Scheppach et al, 1992;Vernia et al, 2003). Although well-controlled clinical trials have not fully verified this finding (Scheppach, 1996;Steinhart et al, 1996), they suggest that butyrate may be effective in a subset of patients.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, this SCFA appears to be of special relevance in relation to the welfare of the colonic epithelium. It is possible that butyric acid has a role in the pathophysiology of colonic disturbances such as ulcerative colitis (Scheppach et al, 1992), the key feature of this disease being a diminished capacity of the colonocytes to utilise butyric acid (Roedinger, 1990).…”
Section: Introductionmentioning
confidence: 99%
“…Activation of IL-8 expression is significantly diminished in Caco-2 cells after spontaneous differentiation by growth to a post-confluent state or after treatment with compounds that inhibit cell proliferation and induce markers of a differentiated phenotype such as vitamin D and sodium butyrate [12]. The effect of butyrate on IL-8 gene expression was of particular interest to us because indirect evidence suggests that it may normally play an important role in modulating the immune response of the colonic mucosa [14][15][16][17][18][19][20]. The only tissue in vertebrates that is normally exposed to substantial levels of butyrate is the mucosa of the colon through the fermentation of carbohydrates by the normal colonic bacterial flora [21,22].…”
Section: Introductionmentioning
confidence: 99%